Brief: Adial Pharmaceuticals Announces Research Collaboration With Medical College Of Wisconsin To Advance Purnovate's Adenosine Compounds As Potential Treatments For Diabetes And NASH
May 19 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION
WITH THE
MEDICAL COLLEGE OF WISCONSIN TO ADVANCE PURNOVATE’S ADENOSINE
COMPOUNDS AS POTENTIAL TREATMENTS FOR DIABETES AND NASH
Source text for Eikon: ID:nGNX3zwLjr
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)